Indian studies performed using different hearing screening protocols have estimated the prevalence of neonatal hearing loss to vary between 1 and 8 per 1000 babies screened. The better prognosis of individual skills like language development, academic success, social integration and successful participation in the society can be attained by early identification and intervention for hearing loss i.e. by 6 months of age. After obtaining permission from the institutional ethical committee all neonates admitted in NICU fulfilling the inclusion and exclusion criteria were taken into the study after obtaining written informed consent from parents/guardian. Information regarding the condition of each neonate was collected in the form of a predesigned questionnaire which included: gestational age; family history of congenital hearing loss and consanguinity; presence of conditions including asphyxia(APGAR score<4), sepsis, respiratory distress syndrome, transient tachypnoea of newborn(TTN),congenital pneumonia, congenial heart disease(CHD) or hyperbilirubinemia(18 mg/d1);and treatments used including phototherapy (>2 days),mechanical ventilation (>5 days),antibiotic therapy including aminoglycosides(>5 days),or oxygen therapy(>1 week and > 40% FIO2). First OAE was done to all 320 neonates among whom 247 (77.8%) passed and 73 (22.8%) came as refer. Among those neonates who failed 1st OAE at first week of life repeat OAE was done around 45 days of age (6weeks). Out of 320 neonates, 73 (22.8%) had failed in 1st OAE, among those 73 only 62 neonates came for second OAE (11 missed for follow up). Of these neonates 57 passed (91.93%) and 5 neonates failed 2nd OAE (8.064%). Out of 5 neonates who had failed in 2nd OAE, BERA was done and 4(80%) neonates failed while 1 passed BERA.